“Every step of the way, the team at Agilent has made working on this complicated project easy. They have tremendous experience with oligo APIs and I could sleep well, knowing I had made a good decision to partner with Agilent.” Director of Manufacturing Operations, Fortune 500 Pharmaceutical Company
Click here to learn more about Agilent Boulder
Efficiently advance your lead therapeutic oligo candidates to clinic, with a common goal of patient health and safety, by partnering with Agilent. Benefit from industry leading experience to…
- Reduce your risk with security of supply from grams to kilograms
- Expedite speed to clinic and scale-up via a robust and rigorous approach to chemical development
- Unparalleled commitment to world class innovation
- Increase your confidence:
- Understand your molecule better with access to the capabilities and services of the world’s leading analytical company
- Dedicated to enabling cost-effective manufacturing of commercial scale quantities of nucleic acids
Advancing your API through development is a long and often complex process that presents unique challenges to every organization. We realize that each customer has distinct needs and customize our programs accordingly.
Agilent provides the analytical expertise, manufacturing capabilities and nucleic acid chemistry knowledge you need to meet these challenges, no matter what the size of your business.
Multi-million dollar capital investments made to the Boulder, Colorado GMP facility demonstrate our commitment to the nucleic acid industry. The facility supports API GMP and non-GMP oligo manufacturing from grams for toxicology work, through 100s of kilograms for commercialization.
Agilent has a proven track record of success with companies of all sizes, because we tailor our internal services to help you obtain your objectives. Unlike some of our competitors, Agilent purely focuses on nucleic acid contract manufacturing, versus development of drugs or delivery technology – we compete with our competitors not our customers.
Experience the peace of mind that comes from partnering with a company that has the financial resources, stability, expertise, focus and vision required for your long-term success.
“As a virtual biotech company, I really appreciate the ability of the Agilent staff to accommodate our needs. They are always available to answer my questions and help guide us.” CEO, Virtual Biotech Company
|
High yielding oligonucleotide manufacturing process |
|
Experience in manufacturing all types of oligo API molecules |
|
Analytical know-how, innovations, and leading edge instrumentation |
|
Process innovations |
|
Product-focused process optimization |
|
Design of Experiments (DOE) and Proven Acceptable Ranges (PAR) expertise |
|
Robust GMP quality systems |
|
In-house stability for API and drug product |
|
Global raw material supply chain networks |